Analyst Price Targets — COWN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 13, 2026 1:28 pm | — | UBS | $135.00 | $38.99 | StreetInsider | ServiceTitan (TTAN) PT Raised to $135 at TD Cowen |
| March 12, 2026 10:27 am | — | UBS | $25.00 | $38.99 | StreetInsider | TD Cowen Reiterates Buy Rating on Netskope (NTSK) |
| February 23, 2026 2:29 pm | — | Truist Financial | $130.00 | $38.99 | StreetInsider | ServiceTitan (TTAN) PT Lowered to $130 at TD Cowen |
| February 18, 2026 1:13 pm | — | Stifel Nicolaus | $55.00 | $38.99 | StreetInsider | eToro Group (ETOR) PT Raised to $55 at TD Cowen |
| February 18, 2026 1:12 pm | — | Stifel Nicolaus | $16.00 | $38.99 | StreetInsider | Beta Bionics, Inc. (BBNX) PT Lowered to $16 at TD Cowen |
| May 2, 2022 8:38 am | — | Piper Sandler | $58.00 | $23.86 | Benzinga | Piper Sandler Maintains Overweight on Cowen, Raises Price Target to $58 |
| May 2, 2022 7:12 am | — | JMP Securities | $60.00 | $22.85 | Benzinga | JMP Securities Maintains Market Outperform on Cowen, Raises Price Target to $60 |
Latest News for COWN
Rivian Automotive Inc (NASDAQ: RIVN)) is inching higher on Tuesday after a senior TD Cowen analyst issued a bullish note in its favour. As Itay Michaeli upgraded RIVN to “buy”, it pushed past its major moving averages (50-day, 100-day) on March 10th, indicating the upward momentum could sustain in the near-term.
Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.
COPENHAGEN, Denmark, March 02, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a virtual fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 11:10 a.m. Eastern Time / 8:10 a.m. Pacific Time in Boston, Massachusetts.
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at TD Cowen and Barclays Conferences.
WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for COWN.
U.S. House Trading
No House trades found for COWN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.